Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity.
Endara
P
P
Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
Vaca
M
M
Chico
M E
ME
Erazo
S
S
Oviedo
G
G
Quinzo
I
I
Rodriguez
A
A
Lovato
R
R
Moncayo
A-L
AL
Barreto
M L
ML
Rodrigues
L C
LC
Cooper
P J
PJ
D000293:Adolescent; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D001250:Asthma, Exercise-Induced / Q000453:epidemiology; D002648:Child; D003233:Conjunctivitis, Allergic / Q000453:epidemiology; D004334:Drug Administration Schedule; D004484:Ecuador / Q000453:epidemiology; D004485:Eczema / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D007559:Ivermectin / Q000008:administration & dosage* / Q000009:adverse effects; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D009855:Onchocerciasis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D015995:Prevalence; D012220:Rhinitis / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors; D012424:Rural Population; D012882:Skin Tests; D013997:Time Factors
D000871:Anthelmintics; D007559:Ivermectin